Internal Server Error

OrigiMed - About the company

OrigiMed is a series B company based in Shanghai (China), founded in 2016 by Catherine Qin and Hui Kang. It operates as a Genetics-based personalized cancer counseling. OrigiMed has raised $10M in funding from IDG Capital and Grand Flight Investment. The company has 684 active competitors, including 179 funded and 137 that have exited. Its top competitors include companies like Guardant Health, Natera and Seer.

Company Details

Genetics-based personalized cancer counseling. By using next-generation high-throughput sequencing technologies, the company carries out comprehensive diagnostics for cancer patients to detect types of cancer. Based on the genetic profile of the patient, the company offers guidance on treatment options and helps patients in better understanding the disease.
Key Metrics
Founded Year
2016
Location
Shanghai, China
Stage
Series B
Total Funding
$10M in 4 rounds
Latest Funding Round
Investors
Ranked
Similar Companies
Sign up to download OrigiMed's company profile

OrigiMed's funding and investors

OrigiMed has raised a total funding of $10M over 4 rounds. Its latest funding round was a Series B round on Jan 03, 2019 for $*****. 1 investor participated in its latest round. OrigiMed has 6 institutional investors.

Here is the list of recent funding rounds of OrigiMed:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Jan 03, 2019
5105359
Series B
6365122
9981431
4154742
8141595
Nov 23, 2018
7499534
Series A
2796675
3757420
6692091
Sep 20, 2016
7127303
Seed
3940555
7689531
lockAccess funding benchmarks and valuations. Sign up today!

OrigiMed's founders and board of directors

Founder? Claim Profile
The founders of OrigiMed are Catherine Qin and Hui Kang.
Here are the details of OrigiMed's key team members:
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

OrigiMed's Competitors and alternates

Top competitors of OrigiMed include Guardant Health, Natera and Seer. Here is the list of Top 10 competitors of OrigiMed, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Guardant Health
Guardant Health
2012, Redwood City (United States), Public
Developer of digital sequencing technology for cancer detection
$557M
79/100
2nd
Logo for Natera
Natera
2004, Redwood City (United States), Public
Developer of cell-free DNA testing for oncology, women’s health, and organ health
$152M
77/100
3rd
Logo for Seer
Seer
2017, San Francisco (United States), Public
Developer of proteomics platform for early detection of cancer and neurological diseases
$128M
72/100
4th
Logo for Tango Therapeutics
Tango Therapeutics
2017, Cambridge (United States), Public
Developer of drugs for the treatment of cancer
$165M
71/100
5th
Logo for Foundation Medicine
Foundation Medicine
2010, Cambridge (United States), Acquired
Provider of genomics-based diagnostics test for cancer
$96.5M
70/100
6th
Logo for Prenetics
Prenetics
2009, Hong Kong (China), Public
Online platform for genetic and diagnostic health testing that helps identify health risks
$67.6M
69/100
7th
Logo for BillionToOne
BillionToOne
2015, San Francisco (United States), Public
Provider of cell-free cancer liquid biopsy test
$389M
69/100
8th
Developer of molecular diagnostics and personalized medicine for cancer
-
68/100
9th
Logo for Caris Life Sciences
Caris Life Sciences
1996, Irving (United States), Public
Developer of panomic disease profiling technologies for cancer precision medicine
$1.23B
66/100
10th
Logo for Maze Therapeutics
Maze Therapeutics
2018, Redwood City (United States), Public
Developer of genetic bio-markers in neurological, metabolic, and renal diseases
$496M
66/100
148th
Logo for OrigiMed
OrigiMed
2016, Shanghai (China), Series B
Genetics-based personalized cancer counseling
$10M
39/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on OrigiMed's competitors? Click here to see the top ones

OrigiMed's Investments and acquisitions

OrigiMed has made no investments or acquisitions yet.

Reports related to OrigiMed

Here is the latest report on OrigiMed's sector:

News related to OrigiMed

•
Bayer, OrigiMed to develop novel cancer therapyBioSpectrum Asia•May 01, 2020•Bayer, OrigiMed
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about OrigiMed

Explore our recently published companies
  • DroneOD - United Kingdom based, 2025 founded, Unfunded company
  • RiskApp - New York based, Unfunded company
  • DataSOS Technologies - Ahmedabad based, 2011 founded, Unfunded company
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford